- Nanorobotics for targeted drug delivery involves using nanoscale robots (1-100 nm) for precise transport and release of therapeutics to specific body locations. This is increasingly vital in modern healthcare due to its ability to deliver drugs with high accuracy and reduce overall side effects
- The growing use of this technology is mainly due to the rising occurrence of diseases needing localized treatment, increasing understanding of the downsides of traditional drug delivery, and a growing desire for more effective and less invasive therapies
- North America is expected to dominate the nanorobotics for targeted drug delivery market with a share of 38.0% due to significant investment in research and development within nanotechnology and nanorobotics, alongside a well-established healthcare infrastructure that facilitates the adoption of advanced treatment modalities
- Asia-Pacific is expected to be the fastest growing region in the nanorobotics for targeted drug delivery market during the forecast period due to increasing investments in healthcare and biotechnology, a growing middle-class population with greater access to advanced medical treatments, and rising healthcare expenditure across countries such as China, Japan, South Korea, and India
- Biochips segment is expected to dominate the market with a market share of 28.5% due to their critical role in enhancing precision drug delivery, biomarker detection, and integration with diagnostic tools, making them highly effective in oncology and personalized medicine applications
